Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement

Susan J. Curry, Alex H. Krist, Douglas K. Owens, Michael J. Barry, Aaron Caughey, Karina W. Davidson, Chyke A. Doubeni, John W. Epling, Alex R. Kemper, Martha Kubik, C. Seth Landefeld, Carol M. Mangione, Michael Silverstein, Melissa A. Simon, Chien Wen Tseng, John B. Wong

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Importance: In the United States, the rate of gonococcal ophthalmia neonatorum was an estimated 0.4 cases per 100000 live births per year from 2013 to 2017. Gonococcal ophthalmia neonatorum can cause corneal scarring, ocular perforation, and blindness as early as 24 hours after birth. In the absence of ocular prophylaxis, transmission rates of gonococcal infection from mother to newborn are 30% to 50%. Objective: To reaffirm the US Preventive Services Task Force (USPSTF) 2011 recommendation on ocular prophylaxis for gonococcal ophthalmia neonatorum. Evidence Review: The USPSTF commissioned a reaffirmation evidence update to identify new and substantial evidence sufficient enough to change its prior recommendation. Findings: Using a reaffirmation process, the USPSTF found no new data that would change its previous conclusion that topical ocular prophylaxis is effective in preventing gonococcal ophthalmia neonatorum and related ocular conditions. The USPSTF found no new data that would change its previous conclusion that there is convincing evidence that topical ocular prophylaxis of all newborns is not associated with serious harms. Therefore, the USPSTF reaffirms its previous conclusion that there is convincing evidence that topical ocular prophylaxis for all newborns provides substantial benefit. Conclusions and Recommendation: The USPSTF recommends prophylactic ocular topical medication for all newborns to prevent gonococcal ophthalmia neonatorum. (A recommendation).

Original languageEnglish (US)
Pages (from-to)394-398
Number of pages5
JournalJAMA - Journal of the American Medical Association
Volume321
Issue number4
DOIs
StatePublished - Jan 29 2019

Fingerprint

Ophthalmia Neonatorum
Advisory Committees
Newborn Infant
Live Birth
Blindness
Cicatrix
Mothers
Parturition

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum : US Preventive Services Task Force Reaffirmation Recommendation Statement. / Curry, Susan J.; Krist, Alex H.; Owens, Douglas K.; Barry, Michael J.; Caughey, Aaron; Davidson, Karina W.; Doubeni, Chyke A.; Epling, John W.; Kemper, Alex R.; Kubik, Martha; Landefeld, C. Seth; Mangione, Carol M.; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien Wen; Wong, John B.

In: JAMA - Journal of the American Medical Association, Vol. 321, No. 4, 29.01.2019, p. 394-398.

Research output: Contribution to journalArticle

Curry, SJ, Krist, AH, Owens, DK, Barry, MJ, Caughey, A, Davidson, KW, Doubeni, CA, Epling, JW, Kemper, AR, Kubik, M, Landefeld, CS, Mangione, CM, Silverstein, M, Simon, MA, Tseng, CW & Wong, JB 2019, 'Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement', JAMA - Journal of the American Medical Association, vol. 321, no. 4, pp. 394-398. https://doi.org/10.1001/jama.2018.21367
Curry, Susan J. ; Krist, Alex H. ; Owens, Douglas K. ; Barry, Michael J. ; Caughey, Aaron ; Davidson, Karina W. ; Doubeni, Chyke A. ; Epling, John W. ; Kemper, Alex R. ; Kubik, Martha ; Landefeld, C. Seth ; Mangione, Carol M. ; Silverstein, Michael ; Simon, Melissa A. ; Tseng, Chien Wen ; Wong, John B. / Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum : US Preventive Services Task Force Reaffirmation Recommendation Statement. In: JAMA - Journal of the American Medical Association. 2019 ; Vol. 321, No. 4. pp. 394-398.
@article{6448f2027d1b431ba1dc90b28b649915,
title = "Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement",
abstract = "Importance: In the United States, the rate of gonococcal ophthalmia neonatorum was an estimated 0.4 cases per 100000 live births per year from 2013 to 2017. Gonococcal ophthalmia neonatorum can cause corneal scarring, ocular perforation, and blindness as early as 24 hours after birth. In the absence of ocular prophylaxis, transmission rates of gonococcal infection from mother to newborn are 30{\%} to 50{\%}. Objective: To reaffirm the US Preventive Services Task Force (USPSTF) 2011 recommendation on ocular prophylaxis for gonococcal ophthalmia neonatorum. Evidence Review: The USPSTF commissioned a reaffirmation evidence update to identify new and substantial evidence sufficient enough to change its prior recommendation. Findings: Using a reaffirmation process, the USPSTF found no new data that would change its previous conclusion that topical ocular prophylaxis is effective in preventing gonococcal ophthalmia neonatorum and related ocular conditions. The USPSTF found no new data that would change its previous conclusion that there is convincing evidence that topical ocular prophylaxis of all newborns is not associated with serious harms. Therefore, the USPSTF reaffirms its previous conclusion that there is convincing evidence that topical ocular prophylaxis for all newborns provides substantial benefit. Conclusions and Recommendation: The USPSTF recommends prophylactic ocular topical medication for all newborns to prevent gonococcal ophthalmia neonatorum. (A recommendation).",
author = "Curry, {Susan J.} and Krist, {Alex H.} and Owens, {Douglas K.} and Barry, {Michael J.} and Aaron Caughey and Davidson, {Karina W.} and Doubeni, {Chyke A.} and Epling, {John W.} and Kemper, {Alex R.} and Martha Kubik and Landefeld, {C. Seth} and Mangione, {Carol M.} and Michael Silverstein and Simon, {Melissa A.} and Tseng, {Chien Wen} and Wong, {John B.}",
year = "2019",
month = "1",
day = "29",
doi = "10.1001/jama.2018.21367",
language = "English (US)",
volume = "321",
pages = "394--398",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum

T2 - US Preventive Services Task Force Reaffirmation Recommendation Statement

AU - Curry, Susan J.

AU - Krist, Alex H.

AU - Owens, Douglas K.

AU - Barry, Michael J.

AU - Caughey, Aaron

AU - Davidson, Karina W.

AU - Doubeni, Chyke A.

AU - Epling, John W.

AU - Kemper, Alex R.

AU - Kubik, Martha

AU - Landefeld, C. Seth

AU - Mangione, Carol M.

AU - Silverstein, Michael

AU - Simon, Melissa A.

AU - Tseng, Chien Wen

AU - Wong, John B.

PY - 2019/1/29

Y1 - 2019/1/29

N2 - Importance: In the United States, the rate of gonococcal ophthalmia neonatorum was an estimated 0.4 cases per 100000 live births per year from 2013 to 2017. Gonococcal ophthalmia neonatorum can cause corneal scarring, ocular perforation, and blindness as early as 24 hours after birth. In the absence of ocular prophylaxis, transmission rates of gonococcal infection from mother to newborn are 30% to 50%. Objective: To reaffirm the US Preventive Services Task Force (USPSTF) 2011 recommendation on ocular prophylaxis for gonococcal ophthalmia neonatorum. Evidence Review: The USPSTF commissioned a reaffirmation evidence update to identify new and substantial evidence sufficient enough to change its prior recommendation. Findings: Using a reaffirmation process, the USPSTF found no new data that would change its previous conclusion that topical ocular prophylaxis is effective in preventing gonococcal ophthalmia neonatorum and related ocular conditions. The USPSTF found no new data that would change its previous conclusion that there is convincing evidence that topical ocular prophylaxis of all newborns is not associated with serious harms. Therefore, the USPSTF reaffirms its previous conclusion that there is convincing evidence that topical ocular prophylaxis for all newborns provides substantial benefit. Conclusions and Recommendation: The USPSTF recommends prophylactic ocular topical medication for all newborns to prevent gonococcal ophthalmia neonatorum. (A recommendation).

AB - Importance: In the United States, the rate of gonococcal ophthalmia neonatorum was an estimated 0.4 cases per 100000 live births per year from 2013 to 2017. Gonococcal ophthalmia neonatorum can cause corneal scarring, ocular perforation, and blindness as early as 24 hours after birth. In the absence of ocular prophylaxis, transmission rates of gonococcal infection from mother to newborn are 30% to 50%. Objective: To reaffirm the US Preventive Services Task Force (USPSTF) 2011 recommendation on ocular prophylaxis for gonococcal ophthalmia neonatorum. Evidence Review: The USPSTF commissioned a reaffirmation evidence update to identify new and substantial evidence sufficient enough to change its prior recommendation. Findings: Using a reaffirmation process, the USPSTF found no new data that would change its previous conclusion that topical ocular prophylaxis is effective in preventing gonococcal ophthalmia neonatorum and related ocular conditions. The USPSTF found no new data that would change its previous conclusion that there is convincing evidence that topical ocular prophylaxis of all newborns is not associated with serious harms. Therefore, the USPSTF reaffirms its previous conclusion that there is convincing evidence that topical ocular prophylaxis for all newborns provides substantial benefit. Conclusions and Recommendation: The USPSTF recommends prophylactic ocular topical medication for all newborns to prevent gonococcal ophthalmia neonatorum. (A recommendation).

UR - http://www.scopus.com/inward/record.url?scp=85060618967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060618967&partnerID=8YFLogxK

U2 - 10.1001/jama.2018.21367

DO - 10.1001/jama.2018.21367

M3 - Article

C2 - 30694327

AN - SCOPUS:85060618967

VL - 321

SP - 394

EP - 398

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 4

ER -